UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.64B |
| 2 |
Eaton
ETN
|
+$670M |
| 3 |
Hewlett Packard
HPE
|
+$663M |
| 4 |
SPDR Gold Trust
GLD
|
+$534M |
| 5 |
JPMorgan Chase
JPM
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$726M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$562M |
| 3 |
Microsoft
MSFT
|
+$557M |
| 4 |
Phillips 66
PSX
|
+$548M |
| 5 |
Boeing
BA
|
+$465M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.49% |
| 2 | Financials | 10% |
| 3 | Healthcare | 7.03% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Industrials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5851
Turning Point Brands
TPB
$1.74B
| $484K | ﹤0.01% |
8,137
-5,466
| -40% | -$338K |
|
|
CRDL
5852
Cardiol Therapeutics
CRDL
$164M
| $483K | ﹤0.01% |
497,857
+263,039
| +112% | +$323K |
|
|
TEM
5853
PUT
Tempus AI
TEM
$9.39B
| $482K | ﹤0.01% |
+10,000
| New | +$540K |
|
5854
Corbus Pharmaceuticals
CRBP
$190M
| $482K | ﹤0.01% |
90,844
+1,467
| +2% | +$12.9K |
|
5855
PUT
Nutrien
NTR
$30.7B
| $482K | ﹤0.01% |
+9,700
| New | +$496K |
|
|
CD
5856
Chaince Digital Holdings
CD
$211M
| $482K | ﹤0.01% |
89,837
+87,562
| +3,849% | +$558K |
|
5857
Finance of America Companies
FOA
$198M
| $481K | ﹤0.01% |
22,643
+18,598
| +460% | +$455K |
|
|
QQQH
5858
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$384M
| $480K | ﹤0.01% |
9,835
+9,769
| +14,802% | +$505K |
|
5859
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $480K | ﹤0.01% |
21,647
+581
| +3% | +$13.6K |
|
5860
iRadimed
IRMD
$1.18B
| $478K | ﹤0.01% |
9,112
-10,688
| -54% | -$600K |
|
5861
Blue Ridge Bankshares
BRBS
$332M
| $478K | ﹤0.01% |
146,657
+6,513
| +5% | +$22.3K |
|
5862
Direxion Daily Regional Banks Bull 3X ETF
DPST
$442M
| $478K | ﹤0.01% |
5,521
-11,027
| -67% | -$1.2M |
|
5863
CALL
Southern Copper
SCCO
$166B
| $477K | ﹤0.01% |
+5,344
| New | +$480K |
|
|
OGI
5864
Organigram Holdings
OGI
$139M
| $476K | ﹤0.01% |
471,597
+363,564
| +337% | +$484K |
|
|
AVR
5865
Anteris Technologies
AVR
$867M
| $475K | ﹤0.01% |
+130,484
| New | +$839K |
|
5866
CytomX Therapeutics
CTMX
$754M
| $475K | ﹤0.01% |
746,788
+238,232
| +47% | +$185K |
|
5867
Cadiz
CDZI
$291M
| $475K | ﹤0.01% |
162,087
-3,151
| -2% | -$13.9K |
|
|
HQL
5868
abrdn Life Sciences Investors
HQL
$627M
| $475K | ﹤0.01% |
37,409
-30,755
| -45% | -$416K |
|
5869
Fidelity Low Volatility Factor ETF
FDLO
$1.46B
| $474K | ﹤0.01% |
7,823
+5,022
| +179% | +$309K |
|
5870
Abeona Therapeutics
ABEO
$413M
| $473K | ﹤0.01% |
99,319
+36,322
| +58% | +$198K |
|
5871
Invesco Golden Dragon China ETF
PGJ
$98.7M
| $473K | ﹤0.01% |
15,963
-12,337
| -44% | -$354K |
|
|
MCI
5872
Barings Corporate Investors
MCI
$345M
| $472K | ﹤0.01% |
20,156
-3,813
| -16% | -$80.2K |
|
5873
Manitowoc
MTW
$675M
| $472K | ﹤0.01% |
54,928
-103,227
| -65% | -$1.01M |
|
|
VLRS
5874
Controladora Vuela Compania de Aviacion
VLRS
$939M
| $472K | ﹤0.01% |
90,374
+66,430
| +277% | +$477K |
|
|
SEZL
5875
Sezzle
SEZL
$3.97B
| $472K | ﹤0.01% |
13,520
-10,102
| -43% | -$428K |
|
Similar funds
UBS Group's Q1 2025 Portfolio in Review
As of Q1 2025, UBS Group held 11,092 positions worth $544B, up 0.53% from $541B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $24.2B of net new capital in Q1 2025, opening 1,201 new positions and adding to 4,607 existing holdings. Its largest new stake was Sandisk: 3,424,800 shares worth $163M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Strategy Inc, an estimated $726M trimmed.
- UBS Group's largest Q1 2025 buy was Sandisk: 3,424,800 shares worth $163M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $1.64B increase.
- UBS Group's biggest Q1 2025 reduction was Strategy Inc, cutting an estimated $726M.
- UBS Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $432M.
- UBS Group's ten largest holdings make up 14% of its $544B portfolio in Q1 2025.
- UBS Group opened 1,201 new positions and closed 931 in Q1 2025.
- UBS Group's portfolio value rose 0.53% quarter-over-quarter to $544B.
Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.